HF is associated with an increased risk for arrhythmia and efsevin was previously suggested to suppress arrhythmogenesis in cardiomyocytes13,14 suggesting a role for VDAC2 also as a protective pathway against arrhythmia. The gene discussed is VDAC2; the disease is Arrhythmia.